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Mucociliary clearance increases with increasing doses of mannitol and clearance is enhanced
when mannitol inhalation is followed by repetitive voluntary coughing.
The aim of the study was to investigate: 1) the effect of increasing doses ofmannitol and repet-
itive coughingon the sputumphysical properties; 2) if the changes in sputumproperties canpredict
the efficacy of mucus clearance measured by radioaerosol technique in bronchiectasis patients.
Sputumwas collected from 14 patients, age: 63 6 yr, who participated on themucociliary and
cough clearance studies at baseline, with mannitol (160, 320 and 480 mg) and control (Daviskas
et al. ERJ 2008; 31:765-772). Sputum was collected: 1) on the screening visit before and after
mannitol challenge (635 mg); 2) at the start and end of each clearance study after 100 repetitive
voluntary coughs except on the control study (no mannitol or repetitive coughing). The sputum
solids content, surface tension, contact angle and rheology were measured.
Mannitol in association with coughing and coughing alone reduced the solids content, surface
tension, contact angle and viscoelastic sputum properties (p< 0.0001) and this effect, unlike mu-
cociliary clearance, was not dose dependent. The control produced no effect. Total mucus clear-
ancecorrelatedonlywith thepercentage reduction in surface tension on480 mgmannitol andwith
the reduction in solids content at baseline.
In conclusion: Inhaledmannitol and voluntary repetitive coughing improved the sputumphysical
properties in bronchiectasis patients and this effect was not dose dependent. Changes in sputum
properties do not predict efficacy of mucociliary and cough clearance.
ª 2009 Elsevier Ltd. All rights reserved.9515 7410; fax: þ61 2 9515 8196.
d.edu.au (E. Daviskas).
9 Elsevier Ltd. All rights reserved.
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Several studies have confirmed that patients with bron-
chiectasis have abnormal clearance of mucus that accu-
mulates in the airways causing chronic cough and recurrent
infections.1e6 Osmotic agents, such as mannitol, improve
clearance of mucus primarily by increasing the hydration at
the airway luminal surface. The increase in mucociliary
clearance acutely after a single dose of mannitol (400 mg)
has been well documented, using a radioaerosol technique,
in patients with bronchiectasis.3,4 In a pilot study, it has
also been shown that 400 mg mannitol reduce the solids
content and surface properties of sputum in patients with
bronchiectasis.7
In a recently published study in patients with bronchi-
ectasis, using a radiaoaerosol technique, we investigated
the effect of increasing doses of mannitol on the muco-
ciliary and cough clearance.5 We reported an increase in
mucociliary clearance that was dose dependent and that
the overall clearance was enhanced when mannitol was
associated with repetitive voluntary coughing.5 The effect
of increasing doses of mannitol and of repetitive coughing
on the sputum physical properties in patients with bron-
chiectasis remained unknown. In addition, the correlation
of the physical properties of sputum with the mucociliary
and cough clearance following treatment has not been
investigated in vivo. If efficacy of the clearance of mucus
following treatment can be predicted from measurements
of the physical properties of sputum, this may minimise
exposure of subjects to radioactivity.
In the present study, in the same subjects with bron-
chiectasis who had mucociliary and cough clearance
measured,5 we investigate: 1) if the effect of mannitol on
the sputum properties is dose dependent; 2) if repetitive
voluntary coughing alone is effective in changing the
sputum properties; and 3) if the efficacy of clearance of
mucus can be predicted by the sputum properties following
treatment in patients with bronchiectasis. The hypothesis is
that the changes in the sputum properties would correlate
with clearance of mucus following treatment.
This study reports the effect of mannitol alone, of
increasing doses of mannitol in association with cough and
of cough alone on the sputum properties in patients with
bronchiectasis. The study also reports the association of the
sputum properties with the clearance of mucus following
treatment that we reported previously in the same patients
with bronchiectasis.5
Materials and methods (details on
Supplementary data)
Subjects
Fourteen subjects, who participated in the mucociliary and
cough clearance studies,5 with stable bronchiectasis,
diagnosed by HRCT, lifelong non-smokers, participated in
the sputum studies (Table 1). All subjects withheld their
regular medication approximately for 20 h on each visit. No
subject was being treated with an antibiotic for an exac-
erbation for at least 4 weeks prior to study or at the time of
the study.The study was approved by the Ethics Review Commit-
tee of Sydney South West Area Health Service (part two,
protocol No: X05 0259) and was performed under the
Clinical Trial Notification Scheme of the Therapeutic
Goods Administration of Australia (CTN No 2005/602).
Written informed consent was obtained from all sub-
jects.
Design of the sputum studies
The study consisted of 6 visits. On visit 1 (screening),
sputum was collected before and after a standard airway
challenge with mannitol. The standard challenge with
635 mg mannitol8 involved 18 spirometric manoeuvres in
total (2 after each dose) and any spontaneous cough
induced by the mannitol.
On visits 2e6, involving mucociliary and cough clear-
ance studies, using a radioaerosol technique,5 sputum was
collected at the start and end of each clearance study
(Table 2). The intervention involved: resting breathing
(baseline study) or inhalation of mannitol (160 or 320 or
480 mg) in a randomised order. Cough clearance during
the last 30 min of the total study time (90 min) involved
100 repetitive voluntary deep coughs (about 4 coughs per
minute). Subjects had 4 successive coughs followed by
rest each minute while in the supine position. The control
day involved no mannitol or repetitive voluntary coug-
hing.
Measurements of the physical properties of sputum
Solids content
The percentage of solids content in the sputum was
calculated by measuring the weight of a 50 mL aliquot of
sputum before and after lyophilization to dryness for 24 h
using a freeze dryer (Kinetics, Stone Ridge, NY, USA).
Interfacial tension (surface tension)
Surface tension was measured with a semiautomatic
tensiometer (Fisher Tensiomat Model no. 21, Fisher Scien-
tific, Pittsburgh, PA) using the du Nouy ring method
described previously.9,10
Wettability (contact angle-glass)
Wettability of mucus, its ability to spread over a solid
planar surface, is characterized by the contact angle (q).11
The contact angle of a 20 mL aliquot of sputum drop on glass
was measured as previously described.7,10
Work of adhesion
The work of adhesion was calculated from the surface
tension and contact angle as follows:
Work of adhesionðWadÞZsurface tension
ð1þ cosðqÞÞmN=m:
Rheology of mucus
The viscosity and elasticity of sputum was measured using
a 20-mL aliquot and a controlled stress rheometer with
Table 1 Mean characteristics and lung function in 14 subjects with bronchiectasis.
Subject Age (yr) Height (cm) FEV1
%
Pred
FEV1
/FVC
%
FEF25e75
%
Pred
%fall FEV1 post 635 mg mannitol
Mean 63 163 77 66 64 5.3
SD 6 7 14 6 22 5.3
Sputum properties in bronchiectasis 373geometry 20 mm, 0.5 aluminium cone and plate (AR 2000,
TA Instruments, New Castle, DE) as previously described.7,10
Statistical analysis
Comparison of sputum properties collected at start and end
of each visit was performed using a 2-factor analysis of
variance (ANOVA with repeated measures). Post-hoc anal-
ysis was performed using Fisher PLSD (protected least
significant difference). Probability values less than 0.05
were considered statistically significant. Pearson’s corre-
lation was performed between the clearance of mucus and
the sputum properties. Statistical analyses were performed
using a statistical package (Statview, Abacus Concepts Inc;
Berkeley, CA, USA).
Results
All sputum properties (%solids, surface tension, contact
angle and viscoelasticity) were significantly reduced after
all doses of mannitol in association with voluntary repeti-
tive coughing and this effect was not dose dependent.
Voluntary repetitive coughing alone (baseline) reduced the
sputum properties to a similar magnitude.
Sputum solids content and surface properties
The solids content, surface tension and contact angle were
significantly reduced after all doses of mannitol in associ-
ation with coughing and after coughing alone (baseline)
(Fig. 1) (p< 0.0001). Initial values on each study day were
similar (mean range: solids: 7.1e7.6%, p> 0.9; surface
tension: 83e86 mN/m, p> 0.7; contact angle: 51e56,
p> 0.05). While the changes were significant with cough-
ing alone and with each mannitol dose, the magnitude of
the reduction in solids content, surface tension and
contact angle after all doses of mannitol and coughing and
after coughing alone, was similar (p> 0.2) (Table 3).
A significant reduction, of similar magnitude, in solids,
surface tension and contact angle was also measured after
635 mg mannitol following the airway challenge on the
screening day, when there were spirometric manoeuvres
but there was no voluntary repetitive coughing
(p< 0.0001) (Fig. 1) (Table 3). The solids content, surface
tension and contact angle remained unchanged in theTable 2 Study design of sputum collection on each visit involvi
Spirometry and
sputum collection
Initial MCC Intervention Post in
15 min 15 min 30 minabsence of mannitol and when there was no repetitive
voluntary coughing as on the control study (Fig. 1) (p> 0.2)
(Table 3).
The work of adhesion was similarly reduced after all
doses of mannitol in association with coughing and with
cough alone (baseline) (p< 0.002) (Fig. 2) (Table 3).
Sputum rheology
The elasticity and viscosity were reduced significantly after
all doses of mannitol in association with coughing and also
after coughing alone (baseline) (p< 0.0005). There was no
significant change for the control study (p> 0.5). The
magnitude of the reduction in elasticity and viscosity after
mannitol and coughing was not dose dependent and it was
not different to coughing alone (p> 0.15) (Table 4). A
significant reduction in elasticity and viscosity was also
measured after 635 mg mannitol alone on the screening day
(p< 0.0001) (Table 4).
There was no significant change in tan d (ratio of
viscosity to elasticity) at 1 rad/s (p> 0.4) but there was at
100 rad/s (p< 0.001).
Assay of mannitol
The amount of mannitol in the sputum collected at the end
of the study was estimated following a validated assay for
measuring mannitol in the sputum supernatant (ARL
Pathology, Melbourne, Australia). Supernatant of sputum
was obtained by ultracentrifuge method at 45,000 revs/
min. The estimate of mannitol in sputum was necessary in
order to ascertain that mannitol was still present in the
airways after all the coughing and that the changes in all
sputum properties were not just due to repetitive coughing
alone. The mean SD amount of mannitol (mg/mL) in the
sputum supernatant was dependent on the inhaled
mannitol dose: 160 mg: 0.079 0.142 mg/mL; 320 mg:
0.2900.582 mg/mL; 480 mg: 1.408 2.059 mg/mL. A
greater amount of mannitol was measured in the sputum
when 480 mg was inhaled compared to when160 and 320 mg
was inhaled (p< 0.03). An even greater amount of mannitol
was measured in the sputum after the 635 mg was inhaled,
10.712 13.842 mg/mL. This value was significantly
greater than that measured in the sputum after the
mannitol (160, 320 and 480 mg) and voluntary coughing
(p< 0.0005).ng mucociliary (MCC) and cough clearance.
tervention MCC Cough clearance Spirometry and
sputum collection30 min
Figure 1 Solids content (A), surface tension (B) and Contact angle (C) in 14 subjects with bronchiectasis at start (black bars) and
at the end (striped bars) of each visit involving: baseline clearance (resting breathing followed by repetitive voluntary coughing
alone), mannitol 160, 320, and 480 mg followed by repetitive voluntary coughing and mannitol 635 mg after challenge on the
screening visit. The control involved no mannitol or voluntary coughing. The solids content, surface tension and contact angle were
significantly reduced after all doses of mannitol in association with voluntary coughing, after mannitol alone (635 mg) and after
coughing alone (baseline visit) (p< 0.0001). There was no significant difference in the magnitude of the reduction in solids content
and surface tension. The reduction in the contact angle after 635 and 480 mg was significantly greater than the reduction after
coughing alone (baseline) (p< 0.05). There was no change in the sputum properties on the control study.
374 E. Daviskas et al.Correlations of sputum properties with
clearance of mucus
The change in the solids content after the repetitive volun-
tary coughing alone (Baseline visit) correlated inversely with
the total whole right lung clearance on the day5 (rZ0.609,
p< 0.02) (Fig. 3). No significant correlation was foundTable 3 Mean reduction (95% CI) from initial values on each st
work of adhesion at the end of each study. All reductions are sign
addition, the magnitude of the reduction in Contact angle with m
Baseline (p< 0.05).
Solids% Surface tensio
mN/m
Control 0(1.0 to 1.0) 1.5(5.8 to 8
Baseline 1.5(0.2e2.8) 4.6(1.6e10.
Mannitol160 mg 1.9(1.0e2.8) 4.8(1.1e8.5)
Mannitol320 mg 1.3(0.2e2.4) 7.1(1.6e12.6)
Mannitol480 mg 2.4(1.1e3.7) 5.6(1.6e9.6)
Mannitol635 mg 2.2(0.7e3.7) 11.6(6.9e16.3between the changes in the surface and rheological prop-
erties and the clearance of mucus after coughing alone.
The % change in surface tension from initial value, when
480 mg mannitol was inhaled in association with coughing,
correlated inversely with the total whole right lung clear-
ance on the day5 (rZ0.569, pZ 0.032) (Fig. 4). The %
clearance by cough over 30 min when 480 mg mannitol wasudy day in solids content, surface tension contact angle and
ificant but similar in magnitude, except on the control day. In
annitol 480 and 635 mg is significantly different compared to
n Contact angle
degrees
Work of adhesion
mN/m
.8) 1.8(1.5 to 5.1) 0.033(8.6 to 8.5)
8) 4.0(1.5e6.5) 2.7(5.0e10.4)
4.4(0.5e8.1) 3.0(4.1e10.0)
5.4(2.8e8.0) 5.2(2.2 to 12.6)
5.1(1.9e8.3) 3.4(2.4 to 9.1)
) 9.9(5.2e14.6) 8.2(1.7e14.7)
Figure 2 Work of adhesion was significantly reduced after all
doses of mannitol in association with voluntary coughing, after
mannitol alone (635 mg) and after coughing alone (baseline)
(p< 0.002).
Sputum properties in bronchiectasis 375inhaled correlated with the amount of mannitol measured
in the sputum5 (rZ 0.680, pZ 0.009).
There were no other significant correlations found
between any of the sputum properties or their changes and
the total clearance of mucus or cough clearance in the
presence of mannitol associated with coughing.
Discussion
This study investigated the changes in the physical properties
of sputum in patients whose mucociliary and cough clearance
was assessed with resting breathing followed by repetitive
voluntary coughing (baseline) and after three doses of
mannitol followed by repetitive voluntary coughing. All
sputum properties (solids content, surface tension, contact
angle and viscoelasticity) were significantly reduced toTable 4 Mean (SD) sputum dynamic elasticity (storage modulu
the start (initial) and end of baseline, mannitol 160, 320, 480 an
G01 Pa
Initial End
Control 23.3 18.1 25.2 15.1
Baseline 31.7 22.7 21.2 19.1*
M160 29.9 23.9 25.2 22.7*
M320 30.7 28.7 22.8 18.9*
M480 24.2 18.1 16.8 11.3*
M635 33.6 26.9 16.3 9.8*
G0100 Pa
Initial End
Control 38.1 25.0 38.0 23.4
Baseline 52.4 53.7 33.2 32.0*
M160 55.4 54.5 40.1 43.5*
M320 56.3 66.1 45.5 34.0*
M480 44.6 30.6 31.2 23.8*
M635 57.4 39.0 28.2 26.4*
* # significantly different from initial value (2-factor AVOVA with repea similar magnitude after all doses of mannitol and coughing
and after coughing alone. There was no significant change in
any of the properties of sputum on the control study when
there was no mannitol or voluntary coughing involved.
In the presence of mannitol, the only sputum property
that was related to the total clearance of mucus was the %
reduction in surface tension after 480 mg and cough. In
addition, the percentage of clearance by cough, 30 min
after this dose, correlated with the amount of mannitol in
the sputum. This dose of mannitol was, however, the
highest dose administered in conjunction with voluntary
cough and significantly more mannitol was still in the
airways after the 100 coughs compared to the lower doses.
It is also a dose close to what is administered clinically
(400 mg) in patients with bronchiectasis.
We expected to find dose dependent changes in the
sputum properties as we did with mucociliary clearance in
the same subjects with bronchiectasis. However, the
changes in the sputum properties, while significant, were
similar in magnitude after all doses of mannitol followed by
voluntary coughing and after coughing alone (baseline
study) and the reason is unclear. It is possible that the
physical properties of sputum collected after 100 voluntary
coughs were mostly influenced by the effect of cough, as
after 100 coughs most mannitol had been cleared from the
airways especially with the lower doses. However, similar
changes in the properties were found following the dose of
635 mg that did not involve voluntary coughing and signifi-
cantly more mannitol was still present in the sputum
compared to the lower doses of mannitol in association
with coughing. It is of interest that similar changes in the
sputum properties were found after increasing doses of
mannitol alone, in asthmatics with excessive secretions,
when there was no voluntary coughing involved.10
The effectiveness of repetitive coughing on the clear-
ance of mucus and its relationship with the changes on the
sputum properties has not been investigated before in
patients with bronchiectasis. It was found that thes G0), dynamic viscosity (loss modulus G00) at 1 and 100 rad/s at
d 635 mg and control visit.
G001 Pa
Initial End
11.9 9.1 12.8 8.6
17.7 19.0 12.8 13.7*
18.4 23.4 14.2 14.7*
16.1 18.2 12.6 12.3*
13.3 8.4 8.8 6.0*
20.1 15.9 8.6 7.0*
G00100 Pa
Initial End
176.9 87.9 166.7 47.5
238.0 184.9 197.9 148.6#
206.6 91.3 202.7 113.6#
165.0 60.2 173.7 96.3#
166.5 43.8 146.6 63.4#
253.1 160.9 170.4 96.3#
ated measures), *p< 0.0005, #p< 0.03.
Figure 3 Correlation between the total whole right lung
clearance and the change from initial value in % solids content
on the baseline study (cough alone, no mannitol) (rZ0.609,
p< 0.02).
376 E. Daviskas et al.reduction in solids content after coughing alone correlated
with the total clearance at baseline. Coughing is regarded
as a mechanical stimulus that can stimulate release of ATP
that can potentially increase the hydration at the airway
lumen.12,13 The reduction in solids content after repetitive
coughing is consistent with an increase in hydration at the
airway lumen. The reduction in surface tension, contact
angle and viscoelasticity is also consistent with an increase
in hydration at the airway lumen. However, there was no
correlation found between the surface and rheological
properties of sputum or their changes and the clearance of
mucus following repetitive coughing alone. In contrast,
simulated repetitive coughing in vitro has been shown toFigure 4 Correlation between the total whole right lung
clearance in response to 480 mg mannitol in association with
voluntary coughing and the % change from initial value in
surface tension (rZ0.569, pZ 0.032).increase mucus transportability that correlated with shear
thinning and a change in viscosity.14
The baseline solids content was around 7%, more
than double the value of solids that is regarded as normal
(2e3%),15 reflecting significant dehydration in this group of
bronchiectasis patients. Dehydration of mucus can occur as
a result of imbalance between the load of mucus secreted
and the water available at the airway surface.15 Dehy-
drated mucus is viscous and sticky and difficult to clear and
mucus transport is significantly decreased as solids increase
from 2.5 to 6%,15,16 consistent with these subjects having
poor mucociliary clearance.5 Mannitol, being an osmotic
agent, creates the driving force for water efflux into the
airway lumen. We proposed that the increase in clearance
with increasing doses of mannitol may relate to the greater
efflux of water into the airway lumen in response to the
higher osmotic forces created. However, we were unable to
find significant differences in the concentration of solids
with the different doses of mannitol and especially after
635 mg and the reason for this surprising finding is unclear.
A significant change in surface tension, work of adhesion
and viscoelastic properties was measured after mannitol
and cough and after cough alone. In our pilot study,
involving a smaller cohort of subjects with bronchiectasis,
we found no change in the viscoelastic properties after
inhalation of 400 mg mannitol.7 However, baseline solids
and viscoelastic properties in the present study were higher
compared to the previous study7 suggesting that these
subjects may have had a more severe disease.
Based on the current findings, changes in the physical
properties of sputum in vivo may guide us to assess the
effect of a treatment qualitatitively, but they do not guide
us to assess efficacy of clearance of mucus with different
treatments quantitatively as measured by the radioaerosol
technique. We were unable to find consistent correlations
between clearance of mucus and any of the sputum prop-
erties or their changes after coughing alone or after
treatment with mannitol and coughing. The only correla-
tion found was between the solids content and clearance
after cough at baseline and between the reduction in
surface tension and clearance after 480 mg of mannitol in
association with coughing. Hasani et al.17 also found no
correlation between clearance during cough and the
viscoelastic properties of sputum. The lack of other
significant correlations in the changes of sputum properties
and clearance of mucus may not be surprising given that
there was no difference in the changes of sputum proper-
ties with increasing doses of mannitol and cough. While the
physical properties of mucus can affect its clearance, the
measurement of the clearance of mucus depends on many
other factors including deposition of the radioactive aero-
sol. In our study the deposition was well controlled within
the same individual between studies and it was predomi-
nantly in the central region. Expectorated sputum origi-
nates from the large airways, however, under stimulated
conditions and after 60 min of treatment, sputum may
originate from smaller airways that has been transported to
the large airways. It is possible that there are limitations to
our technique of sputum collection. Perhaps, different
results may have been obtained if samples of mucus were
collected directly from the lower airways bypassing the
upper airways and avoiding any salivary contamination.
Sputum properties in bronchiectasis 377In conclusion, inhaled mannitol in association with
repetitive voluntary coughing and coughing alone improved
the solids content, surface tension, contact angle, work of
adhesion and viscoelasticity in patients with bronchiec-
tasis. There was no mannitol dose effect in association with
coughing in the improvement of the physical properties of
sputum in patients with bronchiectasis, in contrast to the
effect on the clearance of mucus. This is the first study that
shows a change in the sputum properties after coughing
alone, although it has been suggested that coughing is
a mechanical stimulus and it can potentially increase the
hydration in the airways.12 Repetitive voluntary coughing
can be beneficial in patients with bronchiectasis as it
enhances the clearance of mucus when used shortly after
mannitol inhalation. The findings of this study suggest that
the changes in the sputum properties after treatment may
indicate an improvement in the clearance of mucus but
they may not predict the magnitude of the improvement.Conflict of interest
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